| Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach 2008 · trial group on drugs plus an herbal formulation · Patients with active tuberculosis | 1 g | 26 weeks | 316 |
| Bioavailable turmeric extract for knee osteoarthritis: a randomized, non-inferiority trial versus paracetamol 2021 · Turmeric extract group · Adults aged 40–80 with diagnosed knee osteoarthritis | 1 g | 6 weeks | 97 |
| Efficacy and safety of combination of curcuminoid complex and diclofenac versus diclofenac in knee osteoarthritis: A randomized trial 2020 · Curcuminoid complex plus diclofenac · Adults aged 38–65 years, either sex, with symptomatic knee osteoarthritis | 1 g | 4 weeks | 75 |
| Efficacy of Curcuma longa in treatment of postprandial distress syndrome: An open-label randomized-controlled trial 2019 · 750 mg Curcuma longa group · Adults aged 20–60 with functional dyspepsia and postprandial distress syndrome | 750 mg | 4 weeks | 27 |
| Efficacy of Curcuma longa in treatment of postprandial distress syndrome: An open-label randomized-controlled trial 2019 · 1500 mg Curcuma longa group · Adults aged 20–60 with functional dyspepsia and postprandial distress syndrome | 750 mg | 4 weeks | 26 |
| A Randomized, Placebo-Controlled Study to Evaluate the Effect of Bio-Enhanced Turmeric Formulation on Radiation-Induced Oral Mucositis 2022 · low-dose BTF · Adults with oral cancer who had undergone radical surgery and were receiving concurrent chemoradiotherapy; age and sex not specified | 1 g | 6 weeks | 20 |
| Turmeric improves post-prandial working memory in pre-diabetes independent of insulin 2014 · turmeric · Adults aged 60 years or older with newly recognised, untreated pre-diabetes | 1 g | 1 day | 12 |
| Bioenhancer Assessment of Black Pepper with Turmeric on Self-Reported Pain Ratings in Adults: A Randomized, Cross-Over, Clinical Trial 2026 · Turmeric alone, 1 g · Adults aged 40 years or older with self-reported moderate chronic pain | 1 g | 7 days | 10 |
| Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial 2013 · NR-INF-02 · Patients with primary knee osteoarthritis; adult age range and sex distribution by arm not reported | 1 g | 6 weeks | — |
| Effect of Turmacin supplementation on joint discomfort and functional outcome among healthy participants - A randomized placebo-controlled trial 2020 · Turmacin 0.5 g · Healthy adults subjected to strenuous physical activity; age and sex not specified | 500 mg | 12 weeks | — |
| Effect of Turmacin supplementation on joint discomfort and functional outcome among healthy participants - A randomized placebo-controlled trial 2020 · Turmacin 1 g · Healthy adults subjected to strenuous physical activity; age and sex not specified | 1 g | 12 weeks | — |
| "Evaluation of Curcuma zedoaria Rosc. in the management of non-alcoholic fatty liver Disease: A Randomized, single blind, controlled trial" 2025 · test group · Patients with grade 1 (mild) or grade 2 (moderate) non-alcoholic fatty liver disease; ages and sex not reported | 1 g | 60 days | — |
| Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study 2014 · C. domestica extracts group · Adults aged 50 years or older with primary knee osteoarthritis and knee pain rated at least 5 out of 10; approximately 90% were women | 1.5 g | 4 weeks | 185 |
| Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis 2009 · C. domestica extracts · Patients with primary knee osteoarthritis and pain score ≥5; age and sex not reported | 2 g | 6 weeks | 52 |
| Efficacy and Safety of an Oral Low-Dose Water-Dispersible Turmeric Extract Capsule on Facial Skin Health in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Trial 2025 · WDTE60N group · Healthy women aged 18–40 with at least one facial blemish and otherwise healthy skin | 250 mg | 60 days | 48 |
| A randomized, placebo-controlled, crossover clinical trial to evaluate the effect of a turmeric formulation on muscle soreness and function recovery in moderately active adults 2025 · turmeric formulation (TF) · Healthy, moderately active males and females aged 25–45 years; BMI 18.5–28.0 kg/m² | 300 mg | 5 days | 44 |
| A Randomized, Placebo-Controlled Study to Evaluate the Effect of Bio-Enhanced Turmeric Formulation on Radiation-Induced Oral Mucositis 2022 · high-dose BTF · Adults with oral cancer who had undergone radical surgery and were receiving concurrent chemoradiotherapy; age and sex not specified | 1.5 g | 6 weeks | 20 |
| Bioenhancer Assessment of Black Pepper with Turmeric on Self-Reported Pain Ratings in Adults: A Randomized, Cross-Over, Clinical Trial 2026 · Turmeric alone, 300 mg · Adults aged 40 years or older with self-reported moderate chronic pain | 300 mg | 7 days | 10 |
| Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study 2019 · BCL high dosage · Adults aged 45–80 with symptomatic primary knee osteoarthritis and regular paracetamol and/or oral NSAID use | 93.3 mg | 90 days | 49 |
| Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study 2019 · BCL low dosage · Adults aged 45–80 with symptomatic primary knee osteoarthritis and regular paracetamol and/or oral NSAID use | 93.3 mg | 90 days | 47 |
| Turmeric improves post-prandial working memory in pre-diabetes independent of insulin 2014 · turmeric and cinnamon · Adults aged 60 years or older with newly recognised, untreated pre-diabetes | 1 g | 1 day | 12 |
| Bioenhancer Assessment of Black Pepper with Turmeric on Self-Reported Pain Ratings in Adults: A Randomized, Cross-Over, Clinical Trial 2026 · Turmeric alone, 3 g · Adults aged 40 years or older with self-reported moderate chronic pain | 3 g | 7 days | 10 |
| Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome - a double blind randomized controlled trial - TAK-MetS trial 2015 · Turmeric · Apparently healthy males who screened positive for metabolic syndrome | 2.4 g | 8 weeks | — |
| Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome - a double blind randomized controlled trial - TAK-MetS trial 2015 · Combination · Apparently healthy males who screened positive for metabolic syndrome | 1.5 g | 8 weeks | — |
| Effect of turmeric on glycemic status, lipid profile, hs-CRP, and total antioxidant capacity in hyperlipidemic type 2 diabetes mellitus patients 2019 · turmeric group · Hyperlipidemic patients with type 2 diabetes; age and sex not specified | 2.1 g | 8 weeks | — |
| Analgesic Efficacy of Bromelain and Bromelain Plus Turmeric for Pain Control After Orthodontic Separator Placement: A Triple-Blind Randomized Clinical Trial 2025 · Group C (ANAHEAL PLUS) · Patients older than 15 years receiving orthodontic separators; both sexes | 300 mg | 1 day | 41 |
| A Comparative Study to Evaluate the Efficacy of Curcumin Lozenges (TurmNova(®)) and Intralesional Corticosteroids with Hyaluronidase in Management of Oral Submucous Fibrosis 2021 · Group A · Patients with group III oral submucous fibrosis; age and sex not reported | 300 mg | 90 days | 40 |
| Acute Effects of Turmeric Extracts on Knee Joint Pain: A Pilot, Randomized Controlled Trial 2021 · B-Turmactive · Adults aged 18–65 with mild/moderate knee joint pain | 520 mg | 7 days | 35 |
| Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD) 2019 · Turmeric and chicory seed supplementation (TUR + CHI) · Patients aged 20–60 years with non-alcoholic fatty liver disease and BMI 24.9–40 kg/m² | 3 g | 12 weeks | 23 |
| Efficacy and safety of curcumin in patients with hand osteoarthritis: a pilot double-blinded randomised controlled trial 2025 · curcumin group · Adults over 50 years with hand osteoarthritis and hand pain or stiffness; mostly women | 1.5 g | 90 days | 13 |
| Bioenhancer Assessment of Black Pepper with Turmeric on Self-Reported Pain Ratings in Adults: A Randomized, Cross-Over, Clinical Trial 2026 · Turmeric with black pepper, 300 mg turmeric · Adults aged 40 years or older with self-reported moderate chronic pain | 300 mg | 7 days | 10 |
| Bioenhancer Assessment of Black Pepper with Turmeric on Self-Reported Pain Ratings in Adults: A Randomized, Cross-Over, Clinical Trial 2026 · Turmeric with black pepper, 1 g turmeric · Adults aged 40 years or older with self-reported moderate chronic pain | 1 g | 7 days | 10 |
| Bioenhancer Assessment of Black Pepper with Turmeric on Self-Reported Pain Ratings in Adults: A Randomized, Cross-Over, Clinical Trial 2026 · Turmeric with black pepper, 3 g turmeric · Adults aged 40 years or older with self-reported moderate chronic pain | 3 g | 7 days | 10 |
| Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial 2013 · NR-INF-02 and GS combination · Patients with primary knee osteoarthritis; adult age range and sex distribution by arm not reported | 1 g | 6 weeks | — |
| Curcumagalactomannoside/Glucosamine Combination Improved Joint Health Among Osteoarthritic Subjects as Compared to Chondroitin Sulfate/Glucosamine: Double-Blinded, Randomized Controlled Study 2020 · Group I (CGM-GLN) · Adults with confirmed class I–III osteoarthritis; ages not reported; 38 males and 42 females across both groups | 800 mg | 12 weeks | — |
| Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open-label Parallel-arm Study 2017 · CNTMF (natural turmeric matrix formulation) · Healthy adult men | 500 mg | 1 day | 15 |
| Chili, but not turmeric, inhibits iron absorption in young women from an iron-fortified composite meal 2006 · turmeric meal · Healthy young women | 500 mg | 1 day | 10 |
| Fast pain relief in exercise-induced acute musculoskeletal pain by turmeric-boswellia formulation: A randomized placebo-controlled double-blinded multicentre study 2022 · TBF (Rhuleave-K) · Healthy men and women aged 18–65 with exercise-induced acute musculoskeletal pain | 1.27 g | 1 day | 116 |
| A commercialized dietary supplement alleviates joint pain in community adults: a double-blind, placebo-controlled community trial 2013 · Instaflex · Men and women aged 50–75 with self-reported joint pain lasting more than 3 months | 50 mg | 8 weeks | 49 |
| [Effect of lixu jieyu recipe in treating 75 patients with chronic fatigue syndrome] 2009 · Treated group · Patients with chronic fatigue syndrome; age and sex not reported | 20 g | 90 days | 40 |
| Phytopreventive antihypercholesterolmic and antilipidemic perspectives of zedoary (Curcuma Zedoaria Roscoe.) herbal tea 2016 · G1 (T1; 500 mg ZRDP) · Men aged 25–40 with mild hypercholesterolemia and no diagnosed heart disease | 1 g | 60 days | 10 |
| Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk 2025 · Group I (Curcumin group) · Adults aged 50–74 with type 2 diabetes, hypertension and dyslipidemia, and 10-year ASCVD risk of at least 5%; 33 women and 3 men | 1.5 g | 14 weeks | 36 |
| Comparative Pharmacokinetics of Curcuminoids from Water-Dispersible Turmeric Extract Against a Curcuminoids-Piperine Combination: An Open-Label, Randomized, Balanced, 2-Treatment, 2-Sequence, 2-Period Crossover Study 2024 · WDTE60N test product · healthy adult males; age range not reported | 250 mg | 1 day | 16 |
| A Triple-blind randomized controlled trial on the effects of turmeric versus ginger on inflammatory biomarkers in patients with COVID-19 2025 · Group C (turmeric group) · Adults aged 18 years or older with mild COVID-19 | 1.5 g | 5 days | 44 |
| Effects of turmeric extract on the pharmacokinetics of nifedipine after a single oral administration in healthy volunteers 2008 · combination experiment · 10 healthy volunteers; age and sex not specified | 480 mg | 1 day | 10 |
| Phytopreventive antihypercholesterolmic and antilipidemic perspectives of zedoary (Curcuma Zedoaria Roscoe.) herbal tea 2016 · G2 (T2; 1 g ZRDP) · Men aged 25–40 with mild hypercholesterolemia and no diagnosed heart disease | 2 g | 60 days | 10 |
| Evaluation of the Impact of Different Doses of Curcuma longa L. on Antioxidant Capacity: A Randomized, Double-Blind, Crossover Pilot Trial 2021 · low-dose group (LCG) · Healthy males aged 20–40 years | 1.5 g | 1 day | 9 |
| Effects of turmeric extract supplementation on inflammation and muscle damage after a half-marathon race: a randomized, double-blind, placebo-controlled trial 2020 · CLE · Healthy, normal-weight men who were recreational runners and participated in a half-marathon | 1.5 g | 4 weeks | — |
| The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study 2013 · FTP group · Adults aged 20–70 with elevated ALT levels (>40 IU/L); 56 men and 4 women across the trial, mean age 37.6 years | 3 g | 12 weeks | 30 |
| Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases 2017 · turmeric group · Men and women aged 20–60 with nonalcoholic fatty liver disease and BMI 24.9–40 kg/m2 | 3 g | 12 weeks | 23 |
| Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD) 2019 · Turmeric supplementation (TUR) · Patients aged 20–60 years with non-alcoholic fatty liver disease and BMI 24.9–40 kg/m² | 3 g | 12 weeks | 23 |
| Curcuma decreases serum hepcidin levels in healthy volunteers: a placebo-controlled, randomized, double-blind, cross-over study 2017 · Curcuma · Healthy male volunteers; age not specified | 6 g | 1 day | 18 |
| Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects 2010 · C. longa capsules · Healthy adults aged 25–38 years, seven male and seven female | 6 g | 1 day | 14 |
| Phytopreventive antihypercholesterolmic and antilipidemic perspectives of zedoary (Curcuma Zedoaria Roscoe.) herbal tea 2016 · G3 (T3; 1.5 g ZRDP) · Men aged 25–40 with mild hypercholesterolemia and no diagnosed heart disease | 3 g | 60 days | 10 |
| Evaluation of the Impact of Different Doses of Curcuma longa L. on Antioxidant Capacity: A Randomized, Double-Blind, Crossover Pilot Trial 2021 · moderate-dose group (MCG) · Healthy males aged 20–40 years | 3 g | 1 day | 9 |
| Evaluation of the Impact of Different Doses of Curcuma longa L. on Antioxidant Capacity: A Randomized, Double-Blind, Crossover Pilot Trial 2021 · high-dose group (HCG) · Healthy males aged 20–40 years | 6 g | 1 day | 9 |
| Ability of curcuminoid compared to diclofenac sodium in reducing the secretion of cycloxygenase-2 enzyme by synovial fluid's monocytes of patients with osteoarthritis 2012 · curcuminoid group · Patients with knee osteoarthritis | 90 mg | 4 weeks | — |
| Turmeric supplementation with piperine is more effective than turmeric alone in attenuating oxidative stress and inflammation in hemodialysis patients: A randomized, double-blind clinical trial 2022 · turmeric · Hemodialysis patients aged 20–75 years | 3 g | 12 weeks | — |
| Comparative Pharmacokinetics of Curcuminoids from Water-Dispersible Turmeric Extract Against a Curcuminoids-Piperine Combination: An Open-Label, Randomized, Balanced, 2-Treatment, 2-Sequence, 2-Period Crossover Study 2024 · CPC reference product · healthy adult males; age range not reported | 1.5 g | 1 day | 16 |
| Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study 2011 · trial group · Patients with overt type 2 diabetic nephropathy; age and sex not specified | 1.5 g | 60 days | 20 |
| Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study 2012 · trial group · Patients with relapsing or refractory biopsy-proven lupus nephritis | 1.5 g | 90 days | 12 |
| Cost-Effectiveness of Passion Fruit Albedo versus Turmeric in the Glycemic and Lipaemic Control of People with Type 2 Diabetes: Randomized Clinical Trial 2021 · CURPI group · Patients with type 2 diabetes; age and sex not specified | 500 mg | 120 days | — |
| Effectiveness of the piperine-supplemented Curcuma longa L. in metabolic control of patients with type 2 diabetes: a randomised double-blind placebo-controlled clinical trial 2021 · Curcuma longa L. group · People with type 2 diabetes; age and sex not specified | 500 mg | 120 days | — |
| Turmeric supplementation with piperine is more effective than turmeric alone in attenuating oxidative stress and inflammation in hemodialysis patients: A randomized, double-blind clinical trial 2022 · turmeric/piperine · Hemodialysis patients aged 20–75 years | 3 g | 12 weeks | — |
| A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer--the U.K. NCRN Pomi-T study 2014 · Food supplement group (FSG) · Men aged 53–89 with histologically confirmed prostate cancer, managed with active surveillance or watchful waiting, including men with PSA relapse after radical treatment | 300 mg | 26 weeks | 136 |
| Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product 2017 · Active nutraceutical · Adults with impaired fasting glucose, ages 54.6 ± 11.3 years on average; men and women | 250 mg | 8 weeks | 20 |
| Effects of a Functional Food Mixture on Patients Undergoing Hemodialysis: Preliminary Results Highlighting the Modulation of Uremic Toxins Derived From Microbiota and Antioxidant Markers 2025 · intervention group · Adults with chronic kidney disease undergoing hemodialysis | 130 mg | 8 weeks | 17 |